Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
5188 Results Found
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for
Administration announces agreement with Pfizer to lower drug costs
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by other developed nations — wh
Coalition, including AHA, urges DHS to exempt foreign medical graduates from ‘duration of status’ designation changes
The AHA and a coalition of 42 national organizations yesterday
AHA says HRSA vastly underestimates costs 340B Rebate Pilot Program will inflict on hospitals, urges agency to delay implementation
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program
OSTP seeks comment on laws, regulations hindering AI development and adoption
The Office of Science and Technology Policy issued a request for information Sept. 26 seeking feedback on federal regulations that hinder AI development, deployment, or adoption.
AHA urges DHS to maintain current policy for physicians in U.S. with J-1 visas
The AHA urged the Department of Homeland Security today to maintain “duration of status” as an authorized period of stay for the nearly 17,000 physicians nationwide with J-1 visas who are participating in residency and fellowship programs.
AHA urges administration to make health care personnel exempt from H-1B visa changes
The AHA Sept. 29 asked the Trump administration to provide exemptions for health care personnel from the proclamation issued Sept. 19 announcing changes to the H-1B visa program.
AHA provides recommendations to HHS, CMS for insurers to adhere to prior authorization pledge
The AHA Sept. 29 sent recommendations to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services to help ensure insurance plans adhere to the agencies’ health insurer pledge to reform prior authorization processes.
CMS says premiums, enrollment for MA and Part D to slightly decline for 2026
The Centers for Medicare & Medicaid Services announced Sept. 26 that average premiums for Medicare Advantage and Part D would decline slightly in 2026.
President announces new tariffs, including for certain pharmaceuticals, set to begin Oct. 1
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a company is building its pharmaceutical manufacturing plant in America.